Overview
- 20 inspections across 20 sites are on record.
- 15 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-07.
At a glance
Inspections
20
Sites
20
Observations
15
Career since
Mar 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Topical Pharmaceuticals, Inc. | 7 May 2026 | Human Drugs | On file |
| AbbVie Inc. | 27 Apr 2026 | Human Drugs | |
| SGS North America Inc. | 20 Mar 2026 | Human Drugs | On file |
| Particle Technology Group, LLC | 20 Feb 2026 | Human Drugs | |
| Anesis Life, LLC | 28 Jan 2026 | Human Drugs | On file |
Sites inspected
Topical Pharmaceuticals, Inc.Addison, United States1 insp.
AbbVie Inc.North Chicago, United States1 insp.
SGS North America Inc.Lincolnshire, United States1 insp.
Particle Technology Group, LLCDowners Grove, United States1 insp.
Anesis Life, LLCMacomb, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Michele L Glendenning4 shared
Ramia Brzenjy2 shared
Tyler M Peterson2 shared
Robert J Ham2 shared
Travis V Hull2 shared
Chikitsa S Patel1 shared
Scott D Mcgrew1 shared
Angela C Welker1 shared
Nicholas J Presto1 shared
Elizabeth R Bloom1 shared
Full investigator report
Get the verbatim findings behind Gabriel Bermudez-Picart's 15 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site